Metropolitan Life Insurance CO Collegium Pharmaceutical, Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$31.23 - $40.91 $11,211 - $14,686	-359 Reduced 16.27%	1,847 $71,000
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $6,241 - $7,138	294 Added 15.38%	2,206 $49,000
Q2 2023 Aug 10, 2023	BUY	$21.06 - $24.0 $40,266 - $45,888	1,912 New	1,912 $41,000
Q4 2022 Jun 14, 2023	BUY	$16.14 - $23.55 $35,976 - $52,492	2,229 New	2,229 $51.7 Million
Q3 2022 Jun 14, 2023	BUY	$15.46 - $20.1 $34,460 - $44,802	2,229 New	2,229 $35.7 Million
Q2 2022 Jun 20, 2023	BUY	$14.22 - $20.88 $31,696 - $46,541	2,229 New	2,229 $39,000
Q1 2022 Jun 20, 2023	BUY	$17.2 - $22.5 $38,338 - $50,152	2,229 New	2,229 $45,000
Q1 2022 Mar 30, 2023	SELL	$17.2 - $22.5 $162,213 - $212,197	-9,431 Reduced 80.88%	2,229 $45,000
Q1 2022 May 12, 2022	SELL	$17.2 - $22.5 $162,213 - $212,197	-9,431 Reduced 80.88%	2,229 $45,000
Q4 2021 Jun 21, 2023	BUY	$17.5 - $21.35 $204,050 - $248,941	11,660 New	11,660 $217,000
Q3 2021 Jun 21, 2023	BUY	$17.75 - $25.39 $206,965 - $296,047	11,660 New	11,660 $230,000
Q3 2021 Mar 30, 2023	BUY	$17.75 - $25.39 $14,821 - $21,200	835 Added 7.71%	11,660 $230,000
Q3 2021 Nov 15, 2021	BUY	$17.75 - $25.39 $14,821 - $21,200	835 Added 7.71%	11,660 $230,000
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $235,096 - $273,377	10,814 Added 98309.09%	10,825 $256,000
Q1 2021 Jun 26, 2023	BUY	$19.25 - $26.1 $208,381 - $282,532	10,825 New	10,825 $257 Million
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $208,169 - $282,245	-10,814 Reduced 99.9%	11 $257,000
Q4 2020 Jun 22, 2023	BUY	$17.83 - $22.29 $193,009 - $241,289	10,825 New	10,825 $216,000
Q3 2020 Jun 26, 2023	BUY	$15.78 - $20.82 $170,818 - $225,376	10,825 New	10,825 $225,000
Q2 2020 Jun 26, 2023	BUY	$15.49 - $23.51 $167,679 - $254,495	10,825 New	10,825 $189,000
Q2 2020 Mar 30, 2023	SELL	$15.49 - $23.51 $4,631 - $7,029	-299 Reduced 2.69%	10,825 $189,000
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $4,631 - $7,029	-299 Reduced 2.69%	10,825 $189,000
Q1 2020 Jul 12, 2023	BUY	$13.89 - $25.45 $154,512 - $283,105	11,124 New	11,124 $181,000
Q4 2019 Jul 12, 2023	BUY	$10.7 - $22.24 $119,026 - $247,397	11,124 New	11,124 $228,000
Q3 2019 Jul 12, 2023	BUY	$10.16 - $13.28 $113,019 - $147,726	11,124 New	11,124 $127,000
Q2 2019 Jul 12, 2023	BUY	$10.62 - $16.59 $118,136 - $184,547	11,124 New	11,124 $146,000
Q1 2019 Jul 13, 2023	BUY	$13.58 - $18.72 $151,063 - $208,241	11,124 New	11,124 $168,000
Q1 2019 Mar 30, 2023	BUY	$13.58 - $18.72 $120,794 - $166,514	8,895 Added 399.06%	11,124 $168,000
Q1 2019 May 16, 2019	SELL	$13.58 - $18.72 $91,515 - $126,154	-6,739 Reduced 37.73%	11,124 $168,000
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $91,515 - $126,154	6,739 Added 60.58%	17,863 $97,000
Q4 2018 Jul 13, 2023	BUY	$14.78 - $19.68 $164,412 - $218,920	11,124 New	11,124 $190,000
Q4 2018 Feb 14, 2019	BUY	$14.78 - $19.68 $132,340 - $176,214	8,954 Added 412.63%	11,124 $191,000
Q3 2018 Jul 13, 2023	BUY	$14.16 - $24.3 $157,515 - $270,313	11,124 New	11,124 $164 Million
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $30,727 - $52,731	2,170 New	2,170 $32,000

Others Institutions Holding COLL

# of Institutions

248

Shares Held

36.1M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$190 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$86.3 Million
1.79% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$76.9 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.14M
Shares

$70.2 Million
0.15% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.66M
Shares

$54.3 Million
0.1% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account